| P-006 | Water Crisis Management: Resilience and Sustainability in a SoHO Facility such as Banc de Sang i Teixits de Catalunya | Jaume Vives | |
| P-012 | How cost-effective is Nucleic Acid Testing in the Indian scenario? A single centre study | Angel Sam | |
| P-019 | Life Cycle Assessment (LCA) of Macopharmas RQT DEHT/PAGGSM Reference: A Step Toward Sustainable Practices | Quentin Brebant | |
| P-022 | Supporting a successful rollout of an electronic bedside transfusion system using mixed methods feedback | Andrea Pearce | |
| P-026 | The Transfusion Training Hub - a centralised transfusion training and education resource in the United Kingdom (UK). | Jill Caulfield | |
| P-031 | Improving Blood Sample Accuracy: Impact of Staff Training and Double Verification Protocols on Reducing Rejection Rates | hanna morani | |
| P-034 | Developing a core outcome set for immunoglobulin replacement therapy in cancer to encourage the standardised reporting of outcomes in research and routine care | Catriona Parker | |
| P-41 | Adequacy of Blood Transfusion Guidelines in Non-Surgical Departments at a Third-Level Hospital in Spain | Ericka Castro | |
| P-043 | Optimising Red Cell Unit Management During Amber Alerts - Insights from the UK Red Cell Immunohaematology Laboratory Review | Matthew Hazell | |
| P-048 | Five-year review of the Rare Donor Programme at NHS Blood and Transplant | Emma Watkins | |
| P-053 | Optimizing Blood Bank Efficiency: The Impact of Whole Blood Transfusions on Inventory Management and Resource Utilization | hanna morani | |
| P-057 | Strategies to Reduce Platelet Component Expiration: A Blood Service Experience across Three Hospitals in Catalonia | Laia Ramiro Infante | |
| P-061 | Survey of the Current Status of Blood Transfusion in Remote Areas | Shinichiro Fujiwara | |
| P-064 | Reducing Quality Control (QC) failures in infectious disease serology testing: A comparative study of traditional QC methods and QConnect in a hospital blood bank | Guillermo Orjuela | |
| P-069 | Lessons learned from an implementation of whole blood lysis tube collection for a national tick-borne disease surveillance program in Canadian blood donors. | Steven Drews | |
| P-070 | Conducting root cause analysis on recurrent occurrences and serious non-conformances | Thilakavathi J | |
| P-78 | Implementation of a quality management system for blood componentsin the Blood Service of the Republic of Belarus | Ala Novik | |
| P-080 | Labor, Entrepreneurship and Embodied Learning in the Context of Paid Plasmapheresis | Zsofia Bacsadi | |
| P-083 | Social, ethical, and legal considerations of genomic sequencing in blood donation | Jennie Haw | |
| P-088 | Avis Sovracomunale Medio Varesottos contribution to self-sufficiency of blood components and plasma-derived products | Vincenzo Saturni | |
| P-094 | OPTIMIZING PLASMA DONOR ENGAGEMENT: ENHANCING LOYALTY, RECRUITMENT, AND RETENTION THROUGH DATA-DRIVEN AUTOMATION | Pilar Córdoba | |
| P-103 | Removal of deferrals for vCJD risk: Impact on new and previously deferred donors | Mindy Goldman | |
| P-105 | The most common reasons for temporarily deferrals of donors aged 18-25 for the period from 2019-2025 in Montenegro | Nela Erakovic | |
| P-114 | Lighting Up Catalonia in Red: A Public Health Campaign to Restore Blood Reserves After the Holidays | Pilar Córdoba | |
| P-116 | A CHANGE OF PERSPECTIVE IN DONATION: EXPERIENCE OF VIRTUAL REALITY IN A BLOOD DONATION CAMPAIGN | Agueda Ancochea Serra | |
| P-118 | Impact of Standardized 28-Days Low Haemoglobin Deferral on Donor Return Rates and Successful Donations | ZIN MAR OO | |
| P-127 | Gender-neutral assessment for blood donation, the Australian plan and key differences from international approaches | Veronica Hoad | |
| P-128 | REINTEGRATING DEFERRED BLOOD DONORS: A SUCCESSFUL STRATEGY FOR RECRUITING ANTI-HBc POSITIVE DONORS INTO PLASMA DONATION | Juan-Ramon Grifols Ronda | |
| P-129 | Corporate partnerships and their role in enhancing blood donations: insights from Zimbabwe | Tonderai Mapako | |
| P-146 | Characteristics of blood plasma microparticles in blood donors | Elizaveta Kim | |
| P-164 | Prevalence of iron deficiency and elevated ferritin in new and returned donors after introduction of phased routine ferritin testing for whole blood donations. | Veronica Hoad | |
| P-175 | Is platelet donors safety affected by collection of increasing volumes of concurrent plasma? | Manuel Gutierrez | |
| P-176 | Assessing Safety and Feasibility of Double Platelet Collections with Trima Accel 7 at BST Navarra | Manuel Gutierrez | |
| P-181 | Building Blood Supply Resilience in Northern Israel: An In-House Emergency Donation System | hanna morani | |
| P-182 | Impact of donor and procedural parameters on the platelet yield in plateletpheresis: a retrospective data analysis over a seven-month period | Gorana Ahmetovic-Karic | |
| P-184 | Testosterone Depletion by the Compound Adsorption Device (CAD) in INTERCEPT treated Platelet Units | Susanne Marschner | |
| P-186 | Are US Source Plasma Donors Healthy? A Cross-Sectional Examination of Donation Frequencies, Health Effects, and Reasons for Lapsing | Michelle Fransen | |
| P-187 | Who are US Source Plasma donors? Results from a preliminary analysis. | Michelle Fransen | |
| P-188 | Site surveillance: using bidirectional connectivity to improve safety and productivity of apheresis collections | Manuel Gutierrez | |
| P-198 | A Comprehensive Description of Injuries Reported by Donors with Vasovagal Reaction among Whole Blood Donations in Taiwan | Ching-Mei Yu | |
| P-199 | Current Body Weight Criteria are not Sufficient to Protect Blood Donors of All Ages from Moderate to Severe Vasovagal Reactions: Blood Loss Matters! | Ching-Mei Yu | |
| P-200 | Phlebotomy duration and vasovagal reaction rate | Yared Paalvast | |
| P-202 | Vasovagal reactions by donor age | Mindy Goldman | |
| P-209 | CAN BLOOD DONOR RESEARCH INFORM THE HEALTH SYSTEM FOR OBESITY RESEARCH? | Sheila OBrien | |
| P-210 | Evaluation of the heterogeneity in plasma testosterone among male donors provides insights into genetic and behavioral factors that impact donor health and red blood cell quality characteristics | Tamir Kanias | |
| P-213 | Ascertainment of SARS-CoV-2 Infections and Reinfections and Characterization of Anti-Spike and Nucleocapsid Antibody Levels over Multiple Infection Events | Marion Lanteri | |
| P-225 | EVALUATING MILKY PLASMA FOR SAFE BLOOD TRANSFUSION | Harendrajeet Singh Lamba | |
| P-226 | Evaluation of a new apheresis device | Anaïs Lotens | |
| P-228 | Simulation Study of Transportation of Apheresis Products | Candy Galang | |
| P-234 | Impact of Storage Solutions on Hematocrit Measurement and Red Blood Cell Integrity: A Comparative Study of SAGM and PAGGSM | Quentin Brebant | |
| P-235 | Impact of Sampling Pouch on Hemolysis Measurement: A Comparative Study | Quentin Brebant | |
| P-240 | Quality Control Analysis of Double Dose Pathogen Inactivated Leukodepleted Platelet Concentrates from Buffy Coat Pooling in Platelet Additive Solution: A One-Year Experience | DALIA MORENO | |
| P-245 | Coagulation and microparticle content of spray dried UK plasma in a blood bag | Lucy Bower | |
| P-249 | The Effect of Washing on Potassium Leakage from Red Cells from Individuals with Familial Pseudohyperkalaemia | Athinoula Meli | |
| P-250 | Analysis of the Storage Properties of Red Cells from a Familial Pseudohyperkalaemia Chiswick Donor | Athinoula Meli | |
| P-252 | Quality control of whole blood leuko-reduced with a sparing platelets filter and red blood cells concentrate prepared from whole blood after 8 days of storage at 4C | Laurent Aoustin | |
| P-259 | Qualification of a residual red blood cell counter based on digital microscopy | Anaïs Lotens | |
| P-263 | How Sustainable is our Blood? A Life Cycle Assessment to Determine the Carbon Footprint of Blood Component Production within England | Sean Heveran | |
| P-267 | Comparison of Methods for Enumeration of Residual Leucocytes in Leucoreduced Platelet Products | Esuko Siomi | |
| P-284 | OUR EXPERIENCES IN COLLECTION OF AUTOLOGOUS BLOOD AND PRODUCTION OF SERUM EYE DROPS | Marta erer Vi&269;evi&263; | |
| P-285 | A survey on use of Rh immune globulin during a nationwide shortage | Wen Lu | |
| P-290 | Navigating Challenges in the Plasma Fractionation Industry in Latin America: Insights from Brazil, Argentina, Colombia, and Mexico | Guillermo Orjuela | |
| P-292 | Understanding the civilian demand for dried plasma within Hospitals in England | Rhian Edwards | |
| P-293 | Effects of updated media and communications efforts to increase existing and future plasma donor engagement | Ilana Ostrin | |
| P-294 | Sterilization of Red Blood Cells at Production Scale by Irradiation with UVC Light | Ute Gravemann | |
| P-295 | Validation of the UVC-based pathogen reduction treatment for apheresis platelets and implementation in the routine manufacturing processes at a regional blood service in Germany | Markus Biburger | |
| P-296 | Validation and Implementation of UVC-Treated Buffy-coat derived Platelet Concentrates at a Regional Blood Service in Germany | Ute Gravemann | |
| P-298 | FROZEN IN TIME: HOW DELAYS AFFECT FVIII ACTIVITY IN PLASMA PROCESSING | Sergi Torramadé-Moix | |
| P-299 | PATHOGEN INACTIVATION IN PLASMA, DO GOOD THINGS COME IN SMALL PACKAGES? | Sergi Torramadé-Moix | |
| P-310 | Cord Blood Eye Drops Enhance Healing of Ocular Surface Lesions Resistant to Conventional Therapies | Dinara Samarkanova | |
| P-312 | EVALUATION OF RED CELL CONCENTRATES FROM NON-DEHP TOP AND TOP COLLECTION PACKS THE WELSH EXPERIENCE | Christine Saunders | |
| P-314 | Innovations in Platelet Cryopreservation: Evaluation of DMSO-Free Controlled Rate Freezing and the Role of a Deep Eutectic Solvent as Additional Cryoprotective Agent | Per Sandgren | |
| P-315 | Advancements in blood-derived therapies for ocular surface disorders: A ten-year systematic review. | Jen-Wei Chen | |
| P-321 | Shape changes of cold stored platelets: Can we understand and prevent them? | Allison Waters | |
| P-322 | Rapid and efficient removal of ABO isoagglutinins from high titre plasma and platelet units with a new anti-A/B column | Jose Guerrero | |
| P-325 | Optimising Cell Culture Conditions for Assessing the In Vitro Immunogenicity of Blood Components | Paraskevi Diamanti | |
| P-327 | ENHANCING RED CELL QUALITY: IMPROVED ATP LEVELS, OXYGEN RELEASE RATE, AND FLOWSCORE WITH ADVANCED STORAGE SOLUTION | Peter Smethurst | |
| P-328 | Thrombin Generation in Conventional and Cold Stored Platelet Concentrates: Unveiling the True Drivers Beyond Platelets | Jamie Nash | |
| P-334 | Gathering evidence of the usefulness of Plasmodium sp. NAT screening for malaria at-risk blood donors | Maria Piron | |
| P-342 | Detection of Plasmodium in Blood Donors in Colombia Using a Multiplex NAT Test | Ayda Rodriguez | |
| P-346 | Reinstatement of volunteer blood donors following a false positive test result on HIV Ag/Ab screening test | Nomusa Mashigo | |
| P-354 | Implementing HEV testing in the daily TTI screening process of blood donor samples | Heli Tenkanen | |
| P-355 | Lessons Learned from implementing a new screening assay within NHSBT: what we learned from the HAV/B19 experience | Thusa Sathananthan | |
| P-363 | Specificity performance of ID serology screening assays on first-time blood donors at the Bucharest Blood Transfusion Center, Romania | Walter Melchior | |
| P-367 | Evaluation of Transfusion Transmitted Malaria prevention strategies in Europe | Dragan Jovanovic | |
| P-370 | Prevention of TT-HEV in blood components recipients by implementing donor screening strategy | Magdalena Gudzinska-Adamczyk | |
| P-373 | Challenges and Innovations in Malaria Risk Assessment for Blood Donors: A Singaporean Perspective | Ramir ALCANTARA | |
| P-382 | Optimal Titration and Prevalence of Anti-HBs Among Anti-HBc-positive Blood Donors at a Single Institution in Saudi Arabia | Nawaf Kalo | |
| P-388 | Performance evaluation of a new HCV Ag/Ab combination assay at the Western Cape Blood Service, Cape Town, South Africa | Walter Melchior | |
| P-396 | The impact of easing blood donation deferral policies for men who have sex with men on blood safety and volume: a systematic review of modelling studies | Hans Van Remoortel | |
| P-401 | Rates of syphilis unconfirmed and confirmed donations in Canadian blood donors during a two-year period of epidemiologic, policy and test-based change. | Steven Drews | |
| P-410 | West Nile Virus. Transfusion safety measures taken during the 2024 epidemic outbreak in Andalusia, Spain | María José Romeo | |
| P-415 | First two Usutu human cases identified in blood donors of Catalonia, Spain, through seasonal West Nile Virus screening | Maria Piron | |
| P-417 | Arboviruses: lessons learnt about the preventive strategy implemented in mainland France in blood donations during the 2024 Olympic Games | Syria LAPERCHE | |
| P-419 | Prevalence of HEV infection in Systematic Screening of Blood Donors: Two years of Experience in a Transfusion Center | Esther Franco-Garcia | |
| P-427 | The importance of antibody titre when using soluble recombinant blood group proteins: a case report | Marta Rodriguez Aliberas | |
| P-431 | A intermediate B (AintB): A case report | Saurabh Lahare | |
| P-444 | Improvements in weak and partial RhD detection on the DG Gel Card System | Laziza Amniai | |
| P-449 | Effects of changes in transfusion management, population mix, and fertility on red blood cell alloantibody prevalence in Christchurch, New Zealand | Charlotte Vanhecke | |
| P-454 | DEMONSTRATING RH INCOMPATIBILITY CAUSED BY ALLO ANTI-c ANTIBODY a case study | Adrijana Djurisic | |
| P-458 | Comparison of Two Analysers for ABO/Rh Typing in New Blood Donors | Mei Zhee Lim | |
| P-494 | ANTIBODY CARRYOVER ON AN AUTOMATED AUTOANALYSER | Agueda Ancochea Serra | |
| P-497 | Case study of passenger lymphocyte syndrome in an ABO-mismatch liver transplant | Sim Kuan Lim | |
| P-513 | Red blood cell alloimmunization among hospitalized patients and its significance | Ajsa Zildzic | |
| P-514 | A new solution for managing anti-CD38 interference in plasma testing | Laziza Amniai | |
| P-515 | Initial observations with the use of the DG Gel DC Scan Plus card in a hospital setting | Laziza Amniai | |
| P-516 | Comparison of a soluble CD38 and an anti-CD38 Fab fragment for inhibition of anti-CD38 therapy interference in immunohematology testing | Laziza Amniai | |
| P-517 | Comparative Analysis of Cold-Reacting Antibody Detection: Classic Tube Method Versus Column Agglutination Techniques | Zul Haikhel | |
| P-524 | Genetic and serological characterization of a RHD*c.351delC variant in four Caucasian female probands | Pernille Rasmussen | |
| P-538 | The importance of Molecular Typing and Perfect Match Transfusion in Sickle Cell Disease: An Experience of a Transfusion Medicine Department in Portugal | Carmen Faria | |
| P-555 | Novel RHD variant with demonstrated risk of RhD alloimmunisation in a cohort of Australian Indigenous population | Emma Palfreyman | |
| P-557 | CD36 variants of clinical relevance identified at Australian Red Cross Lifeblood | Emma Palfreyman | |
| P-576 | Platelet transfusion refractoriness in oncohaematological patients | Elizaveta Kim | |
| P-579 | Automated Solid Phase Platelet Antibody Detection Assay | Marcie Jaffee | |
| P-600 | Evolution of Alloantibodies in Pregnant Patients and Evaluation of Screening Methodology | Daniel Lacomba | |
| P-605 | A report of a successful pregnancy in a P1k phenotype individual with anti-P and anti-PX2 | Catherine Booth | |
| P-650 | Real-world red blood cell transfusion practice and cardiac outcomes in patients with myelodysplastic syndromes (MDS) | Allison Mo | |
| P-651 | Intention to comply does not equal compliance | Susan MacCallum | |
| P-652 | Impact of Stored Red Blood Cell Age on Post-Transfusion Hyperkalemia: A Retrospective Analysis | hanna morani | |
| P-656 | Risks of Alloimmunization and Hemolysis of RhD-Mismatched Hematopoietic Stem Cell Transplants: A BEST Collaborative Study | Valery Kogler | |
| P-659 | Audit of the use of cryopreserved platelets in Girona | Jordi Piedra Sanchez | |
| P-662 | Fibrinogen concentrate is a safe and comparable alternative to cryoprecipitate in critical bleeding : a retrospective audit from the Royal Hospital for Women | Susan MacCallum | |
| P-678 | Transfusion Support for an IgA-Deficient Patient: Component Development, Donor Call-Up, and Clinical Management within Quality Principles | Sara Wright | |
| P-684 | Korean Haemovigilance System Annual Report of 2024 | Jungwon Hyun | |
| P-699 | Comparative analysis of ABO-incompatible red cell transfusion and near-miss events in France | Aline Mirrione Savin | |
| P-710 | Survey on strategies for optimal use of Rh-D negative blood | Birgit Gathof | |
| P-711 | Baseline Data for Patient Blood Management Implementation: A Study of elective Hip and Knee Replacement Patients at a University Hospital in Lebanon | Hanady Samaha | |
| P-715 | Declining trends in Blood Utilization for Revision Hip and Knee Arthroplasty in Taiwan | Ling-I Hsu | |
| P-726 | Patient Blood Management - are hospitals complying with national guidance? | John Grant-Casey | |
| P-727 | Comparison of oxyhemoglobin dissociation in cardiothoracic surgery patients receiving blood transfusions vs. non-transfused patients | Aidan Murray | |
| P-739 | INCIDENCE OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN SOUTHERN ITALY (CALABRIA REGION), AREA OF COSENZA, YEARS 2021-2024 | Livia Bernardi | |
| P-750 | Reducing Central Venous Catheter use in Stem Cell and Lymphocyte Leukacytapheresis with Fenestrated Peripheral Catheters | Agueda Ancochea Serra | |
| P-762 | Automated hollow-fiber perfusion system for large-scale expansion of suspension cells | Eric Bräuchle | |
| P-789 | Effects of donor and component factors on hemoglobin increments after red blood cell transfusion in patients with chronic kidney disease: a vein-to-vein study | Wen-Jie Liu | |
| P-791 | Blood donors views on uses of genetic information by the blood operator | Jennie Haw | |
| P-799 | New technologies to achieve maximum efficiency in the production of Platelet Concentrates | Manuel Gutierrez de Rave | |
| P-801 | Enhanced transfusion medicine data analytics in the machine learning era: insights from Zimbabwe | Tonderai Mapako | |
May 31 - June 4 2025 Milan

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|